Technical Analysis for VALN - Valneva SE
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 13.40 | -1.02% | -0.14 |
VALN closed down 3.49 percent on Monday, January 30, 2023, on 1.89 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | -1.02% | |
Oversold Stochastic | Weakness | -1.02% | |
20 DMA Resistance | Bearish | -4.47% | |
Crossed Above 50 DMA | Bullish | -4.47% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -4.47% | |
Stochastic Reached Oversold | Weakness | -4.47% | |
Inside Day | Range Contraction | -4.47% | |
Gapped Up | Strength | -4.47% | |
Oversold Stochastic | Weakness | -4.47% | |
20 DMA Resistance | Bearish | -2.46% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Gap Up Closed | 18 minutes ago |
Fell Below Previous Day's Low | 18 minutes ago |
Down 1% | 18 minutes ago |
Reversed from Up | 18 minutes ago |
Possible NR7 | about 1 hour ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/10/2022
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Infectious Diseases Vaccines Vaccination Medical Research Virology Lyme Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Infectious Diseases Vaccines Vaccination Medical Research Virology Lyme Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 40.3 |
52 Week Low | 9.77 |
Average Volume | 4,246 |
200-Day Moving Average | 18.13 |
50-Day Moving Average | 13.97 |
20-Day Moving Average | 14.28 |
10-Day Moving Average | 14.74 |
Average True Range | 0.81 |
RSI | 44.13 |
ADX | 11.34 |
+DI | 20.64 |
-DI | 25.31 |
Chandelier Exit (Long, 3 ATRs) | 13.59 |
Chandelier Exit (Short, 3 ATRs) | 15.06 |
Upper Bollinger Bands | 15.86 |
Lower Bollinger Band | 12.71 |
Percent B (%b) | 0.26 |
BandWidth | 22.07 |
MACD Line | 0.09 |
MACD Signal Line | 0.23 |
MACD Histogram | -0.1419 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.79 | ||||
Resistance 3 (R3) | 14.89 | 14.57 | 14.58 | ||
Resistance 2 (R2) | 14.57 | 14.26 | 14.52 | 14.51 | |
Resistance 1 (R1) | 14.06 | 14.06 | 13.90 | 13.96 | 14.44 |
Pivot Point | 13.74 | 13.74 | 13.67 | 13.69 | 13.74 |
Support 1 (S1) | 13.23 | 13.43 | 13.07 | 13.13 | 12.64 |
Support 2 (S2) | 12.91 | 13.23 | 12.86 | 12.57 | |
Support 3 (S3) | 12.40 | 12.91 | 12.50 | ||
Support 4 (S4) | 12.30 |